Active Ingredients

In this episode of the Active Ingredients podcast, host Thomas Dove speaks with Abbie Celniker, Partner at Third Rock Ventures.

Abbie Celniker has spent four decades in the life sciences, from early scientific roles at Genentech to Chief Executive Officer (CEO) positions at Taliesin and 11 Biotherapeutics, and now as a partner at Third Rock Ventures, creating and developing new biotech companies.

In this conversation, she shares what it means to be a biotech pioneer, why the CEO should act as an emcee (master of ceremonies), and how patient urgency shaped the first generation of company builders. She also covers investor-operator dynamics and what the next generation of leaders will need to succeed.

Click or tap the play button to watch the video or tune in on Spotify, Apple Podcasts or Amazon Music.

Key Takeaways

• Learn why authenticity and trust are practical foundations of biotech leadership, not soft skills, and how they hold high-risk teams together when the science becomes uncertain.
• Discover how patient urgency drove the first generation of biotech builders, and what that mission-driven instinct means when creating new life science companies today.
• Understand the CEO-as-emcee principle: how surrounding yourself with domain experts and stepping back from the spotlight creates stronger results across every function.
• Explore why letting go of execution is a requirement at senior level, and how staying too close to the data holds your team and your organisation back.
• Gain insight into what an integrated leadership team looks like at each company stage, and how to stop internal competition from undermining collective decision-making.
• Identify the tension between investor and operator perspectives on boards, and why balancing those viewpoints leads to better scientific and strategic decisions.
• Take away practical advice for stepping into senior leadership before you have all the experience: why your executive team must act as thought partners, not simply direct reports.

Snippets

• "All of a sudden, you don't have any real line oversight of the people who are doing the work for you. You have to lead by influence, and you need to get things done."
• "I want every single person I hire to know more than I do. I want them to be more expert in every area... I just want them to be superstars."
• "If they're constantly so out looking to grab the spotlight, they're going to potentially be missing opportunities to be motivating some of the superstars that can actually deliver the goods."

Timestamps & Topics

The following timestamps are approximations:

• [00:00] – Intro: Abbie Celniker’s four-decade career across biotech and life sciences
• [01:30] – Active Ingredients: Authenticity, trust, and culture as leadership foundations
• [07:35] – Career Start: Joining Genentech in 1986 and the power of cross-functional project teams
• [16:38] – Biotech Pioneers: How patient urgency defined the first generation of company builders
• [29:09] – Letting Go: Why moving from execution to leadership is a requirement, not a choice
• [37:25] – CEO as Emcee: Leading through experts rather than being the expert in the room
• [45:41] – Boards and Investors: Navigating operator-investor tension at board level

Resources

• Follow Abbie Celniker on LinkedIn: https://www.linkedin.com/in/abbie-celniker-277a356/
• Follow Thomas Dove on LinkedIn: https://www.linkedin.com/in/lifesciencesexecutivesearch/

Don't Miss an Episode

Sign up to the Active Ingredients podcast at ⁠⁠⁠⁠⁠⁠⁠⁠www.activeingredients.fraserdove.com⁠⁠⁠⁠⁠⁠⁠⁠.

Remember to tune into our next episode for more inspiring insights. You can also subscribe to the Active Ingredients podcast on ⁠⁠⁠⁠⁠⁠⁠⁠Apple Podcasts⁠⁠⁠⁠⁠⁠⁠⁠, ⁠⁠⁠⁠⁠⁠⁠⁠Amazon⁠⁠⁠⁠⁠⁠⁠⁠, ⁠⁠⁠⁠⁠⁠⁠⁠Spotify⁠⁠⁠⁠⁠⁠⁠⁠, ⁠⁠⁠⁠⁠⁠⁠⁠YouTube⁠⁠⁠⁠⁠⁠⁠⁠ and other leading podcast platforms.

Loved this episode?

Share it with your friends, family, or your peers!

In this episode of the Active Ingredients podcast, host Thomas Dove interviews Paula Gildert, Strategic Advisor & Board Member, Xyant Services.

Paula Gildert is a procurement and transformation leader who has worked across AstraZeneca, Novartis and Takeda. She served as President and Chair of the Chartered Institute of Procurement and Supply (CIPS) and now advises life sciences organisations on strategy and governance.

Paula reveals how values, courage, and commitment fuel her leadership style. She shares frameworks for breakthrough thinking, champions speed and quality over pure cost, and vividly describes her journey from corporate executive to board advisor.

Key Takeaways

• Experience how courage, authenticity, and commitment ignite leadership and help senior leaders build trust across the pharmaceutical landscape.
• See why “context is decisive” in transformation. Gildert shows how reading your team’s environment sets every strategy in motion.
• Unlock how breakthrough thinking turns stretch goals into tangible results by zeroing in on what’s missing and boldly making clear promises.
• Discover how speed and quality ignite value creation in procurement and watch cost savings flow naturally as business processes evolve.
• Gain practical advice on keeping teams energised during multi-year change by celebrating progress and keeping senior leadership visibly engaged.
• Identify how communication training gives leaders a lasting edge. Gildert explains why structured frameworks for conversations pay dividends across every setting.
• Explore how a Royal Marine upbringing shaped Gildert’s early leadership. She traces her resilience, her ability to hold her ground and her openness to being wrong back to her father’s influence.
• Sharpen your listening and curiosity as a young leader. Gildert shares how face-to-face conversations and focus groups shape strategy from the ground up.
• Use Gildert’s “third chapter” story as inspiration to shape your own vibrant move from executive to impactful advisory, board and voluntary roles.

Snippets

• Business is mostly bad news with a spattering of good. If you’re in a high change environment, it’s not a balance.”
• “Once you work in the pharmaceutical industry, and you’re driven by a higher purpose, everything else will pale in comparison.”
• “Oftentimes, you have the team you need. You just haven’t rallied them around the right challenge.”

Timestamps & Topics

The following timestamps are approximations:

• [00:00] – Intro: Paula Gildert’s leadership journey in the life sciences
• [01:37] – Key Ingredients: Values, authenticity and commitment
• [03:51] – Early Influences: Growing up with Royal Marine leadership
• [16:29] – Delivering Impact: Inspiring teams through large-scale change
• [23:12] – Value Creation: Why speed and quality beat cost in procurement
• [27:03] – Breakthrough Thinking: Turning stretch goals into real results
• [34:30] – Emotional Intelligence: Leading when values don’t align
• [46:09] – Third Chapter: Leadership beyond the corporate org chart
• [56:50] – Future of Life Sciences: Access, affordability and new technology

Resources

• Follow Paula Gildert on LinkedIn: https://www.linkedin.com/in/paula-gildert-547b987/•
• Follow Thomas Dove on LinkedIn: https://www.linkedin.com/in/lifesciencesexecutivesearch/

Don't Miss an Episode

Sign up to the Active Ingredients podcast at ⁠⁠⁠⁠⁠⁠⁠www.activeingredients.fraserdove.com⁠⁠⁠⁠⁠⁠⁠.

Remember to tune into our next episode for more inspiring insights. You can also subscribe to the Active Ingredients podcast on ⁠⁠⁠⁠⁠⁠⁠Apple Podcasts⁠⁠⁠⁠⁠⁠⁠, ⁠⁠⁠⁠⁠⁠⁠Amazon⁠⁠⁠⁠⁠⁠⁠, ⁠⁠⁠⁠⁠⁠⁠Spotify⁠⁠⁠⁠⁠⁠⁠, ⁠⁠⁠⁠⁠⁠⁠YouTube⁠⁠⁠⁠⁠⁠⁠ and other leading podcast platforms.

Loved this episode?

Share it with your friends, family, or your peers!

In this episode of the Active Ingredients podcast, host Thomas Dove interviews Gaurav Jain, Chief Commercial Officer (CCO) at Modavar Pharmaceuticals LLC.

Gaurav Jain is a globally experienced commercial leader with over 22 years in the pharmaceutical industry. He has led business development and mergers and acquisitions (M&A) across branded generics, orphan drugs, and multinational companies in markets spanning Asia, the United States, and beyond.

In this conversation, Gaurav explains how he entered the industry by chance and built his career by setting clear goals, staying adaptable, and taking on challenges beyond his experience. He also shares how pharma deal structures have shifted away from large upfront payments toward models in which both partners share risk based on a product's performance. He also discusses how senior leaders can protect their organisations from the disruption caused by rising trade barriers and global supply chain instability.

 Key Takeaways

• Learn why clear objective setting forms the foundation of effective leadership in pharmaceutical organisations, and how defining deliverables from day one gives teams direction and prevents wasted effort.
• Discover how Gaurav Jain's career path from banking into branded generics and M&A shows that subject matter expertise matters less than the ability to work with experts and ask the right questions.
• Understand how to build high-performing commercial teams by hiring for motivation and mindset rather than industry knowledge alone, and why open dialogue leads to stronger business outcomes.
• Explore how performance-based deal structures have replaced front-loaded payments in pharmaceutical partnerships, and why shared risk now underpins long-term commercial relationships of all sizes.
• Identify the steps senior leaders should take to protect their organisations from rising global trade barriers, including diversifying supply chains, monitoring P&L exposure, and engaging proactively with policymakers.

Snippets

•  "You don't need to be an expert in every space. What you need to know is how experts perform in their own space, and how to work with the experts to learn enough to work along with the greater organisation."

• "Even after you close the deal, it's not the end. It's kind of a beginning of another major set of challenges... You might have a great idea, but if you don't really follow up on those ideas during integration, you kind of lose value."

• "A lot of times I've seen industry professionals look at AI as something that can just shorten the amount of thinking they need to do. AI is not a substitute to strategy, to vision, to thinking, to a challenge."

  
  

Timestamps & Topics

The following timestamps are approximations:

• [00:29] Key Ingredients: Objective setting, adaptability and strategic planning
• [00:31] Career Path: From banking into the pharmaceutical industry
• [00:47] Deal Making: What makes M&A a genuine breakthrough for an organisation
• [00:54] Partnership Evolution: How deal structures have shifted to performance-based models
• [00:59] Trade Barriers: Navigating geopolitical disruption and supply chain risk
• [01:07] Future of Leadership: AI, data and the next generation of life sciences leaders

Resources

• Follow Gaurav Jain on LinkedIn: https://www.linkedin.com/in/gaurav-jain-032b9417/

• ResourcesFollow Thomas Dove on LinkedIn: https://www.linkedin.com/in/lifesciencesexecutivesearch/

Don't Miss an Episode

Sign up to the Active Ingredients podcast at ⁠⁠⁠⁠⁠⁠www.activeingredients.fraserdove.com⁠⁠⁠⁠⁠⁠.

Remember to tune into our next episode for more inspiring insights. You can also subscribe to the Active Ingredients podcast on ⁠⁠⁠⁠⁠⁠Apple Podcasts⁠⁠⁠⁠⁠⁠, ⁠⁠⁠⁠⁠⁠Amazon⁠⁠⁠⁠⁠⁠, ⁠⁠⁠⁠⁠⁠Spotify⁠⁠⁠⁠⁠⁠, ⁠⁠⁠⁠⁠⁠YouTube⁠⁠⁠⁠⁠⁠ and other leading podcast platforms.

Loved this episode?

Share it with your friends, family, or your peers!

In this episode of the Active Ingredients podcast, host Thomas Dove interviews Gabriel Morelli, Global Freelance Consultant, Advisor and Certified Mentor and Coach.

Gabriel Morelli has spent over 25 years in life sciences, spanning generics, CDMOs, consulting and private equity-backed organisations. His career began in Montevideo, was redirected by a British Council scholarship MBA at Cranfield, and has since evolved into an independent advisory practice across the pharma value chain.

In this conversation, he explains why most generics and CDMO companies chase the wrong metrics, how to assess a new role within 90 days, and why the freelance leap demands more preparation than most executives expect.

Key Takeaways

• Learn why integrity, curiosity and genuine interest in people are Gabriel's three non-negotiable leadership qualities, shaped across generics, CDMOs and private equity.

• Discover how the systemic view of commercial excellence separates strong generics and CDMO businesses from those that optimise one element while quietly failing everywhere else.

• Understand why private equity operates by different rules from corporate life, and why more than half of senior hires struggle once the armies of support are gone.

• Explore Gabriel's 90-day rule for assessing whether you can succeed in a new role, and why acting on an honest answer early signals clarity rather than weakness.

• Apply the planning principles behind a credible freelance advisory career: a defined niche, consulting skills and commercial fitness before leaving corporate employment.

• Gain a clearer view of idea diversity and why teams built around genuine intellectual friction produce stronger outcomes than diversity defined by demographics alone.

• Identify why the value most senior executives believe they carry is tied to their company and title, and why most discover this too late to act.

• Uncover how Gabriel grew from 5,000 to 22,000 LinkedIn followers through daily publishing, and why a consistent point of view wins more advisory work than any CV.

• Take away why adaptability will define the next generation of life science leaders as geopolitics, technology and talent continue to accelerate.

Snippets

• “The moment you feel that you will not be successful, just push the eject button, disappear, and, focus on something else.”

• “It doesn’t really matter if you do something great downstream. If upstream, you’re doing everything wrong… it’s better to do everything average than to be great at KPIs.”

• “I’m not so fixated on the diversity, equity and inclusion… To me, what is important is, is ideas… You want people with different ideas with some tensions, some friction, but it needs to be operational.”

Timestamps & Topics

The following timestamps are approximations:

• [00:00] –– Intro: Gabriel Morelli’s career across generics, CDMOs, consulting and private equity

• [04:14] –– Career Origins: From Montevideo to Cranfield and the MBA that led to life sciences

• [18:47] –– Commercial Strategy: The systemic gap in commercial excellence across generics and CDMOs

• [21:59] –– Private Equity: Cash discipline, no place to hide, and why most corporate hires struggle

• [29:20] –– Quit Fast: The 90-day rule and why staying for appearances is the wrong move

• [35:29] –– Second Wave: Defining a niche and why LinkedIn replaces traditional business development

Resources

• Follow Gabriel Morelli on LinkedIn: https://www.linkedin.com/in/morelligabriel/

• Follow Thomas Dove on LinkedIn: https://www.linkedin.com/in/lifesciencesexecutivesearch/

Don't Miss an Episode

Sign up to the Active Ingredients podcast at ⁠⁠⁠⁠⁠www.activeingredients.fraserdove.com⁠⁠⁠⁠⁠.

Remember to tune into our next episode for more inspiring insights. You can also subscribe to the Active Ingredients podcast on ⁠⁠⁠⁠⁠Apple Podcasts⁠⁠⁠⁠⁠, ⁠⁠⁠⁠⁠Amazon⁠⁠⁠⁠⁠, ⁠⁠⁠⁠⁠Spotify⁠⁠⁠⁠⁠, ⁠⁠⁠⁠⁠YouTube⁠⁠⁠⁠⁠ and other leading podcast platforms.

Loved this episode?

Share it with your friends, family, or your peers!

In this episode of the Active Ingredients podcast, host Thomas Dove interviews Laura O'Brien, Global Operations and Quality Executive.

Laura O'Brien is one of the most experienced operations and quality leaders in pharma manufacturing, having held VP and SVP roles at Sanofi, Novartis and CSL across four site head roles in the UK and beyond.

In this conversation, she shares what it means to be the first female leader on a manufacturing site, how to build and retain world-class teams, and why shifting from direct control to influence is a defining challenge for global pharma leaders.

Key Takeaways

• Learn why Laura O'Brien's three leadership ingredients (authentic, bold, and connected) are daily disciplines tested by the pressures of senior pharma leadership, not abstract values on a wall.

• Discover how mentors become sponsors, and why the most career-defining moments come from being placed in roles you never felt ready for.

• Understand why the site head role is the single most important step in a manufacturing leader's career, blending total site accountability with board-level visibility.

• Explore how to make the shift from direct control at site level to leading by influence across a global network of pharma manufacturing sites.

• Apply Laura's hiring framework: going beyond competency-based interviews to find candidates who will genuinely transform the organisation at this specific point in time.

• Gain a new perspective on the number one team concept, and why your strongest professional loyalty should sit with your peer group rather than the team you directly manage.

• Uncover what walking the talk really demands from a senior leader, and why authentic role modelling is the only reliable way to build lasting organisational alignment.

• Take away Laura's advice on balancing a demanding pharma career with family life, and why trading off rather than trying to do everything perfectly is the smarter long-term strategy.

• Identify the difference between a mentor and a sponsor, and why true sponsorship means advocating for someone at board level, not just offering guidance.

Snippets

• "People will not align behind you if they don't see that you believe in it and [that] you're engaged in it too."

• "Don't try to be perfect. In my view, it's impossible if you really want to do all of these things really well. So trade off one against the other at different times."

• "Surround yourself with the best people... what I'm really looking for is: is this person going to transform the organisation in the way it needs to be transformed at this point in time?"

Timestamps & Topics

The following timestamps are approximations:

• [05:20] -- Intro: Laura O'Brien's background in global pharma operations and quality

• [06:48] -- Active Ingredients: Authentic, bold, and connected as the pillars of leadership

• [10:24] -- Career Origins: From pharmacy school to a purposeful industrial pharma career

• [17:20] -- Site Head: The role that shaped Laura's leadership, including being the first female site head

• [26:16] -- Team Building: Hiring for transformation, not just competency

• [38:33] -- Global Leadership: Shifting from direct control to influence across a network

• [57:54] -- Future of Pharma: AI, patients, and the leadership qualities that will always matter

Resources

• Follow Laura O'Brien on LinkedIn: https://www.linkedin.com/in/laura-o-brien-4556557/

Follow Thomas Dove on LinkedIn: https://www.linkedin.com/in/lifesciencesexecutivesearch/

Don't Miss an Episode

Sign up to the Active Ingredients podcast at ⁠⁠⁠⁠www.activeingredients.fraserdove.com⁠⁠⁠⁠.

Remember to tune into our next episode for more inspiring insights. You can also subscribe to the Active Ingredients podcast on ⁠⁠⁠⁠Apple Podcasts⁠⁠⁠⁠, ⁠⁠⁠⁠Amazon⁠⁠⁠⁠, ⁠⁠⁠⁠Spotify⁠⁠⁠⁠, ⁠⁠⁠⁠YouTube⁠⁠⁠⁠ and other leading podcast platforms.

Loved this episode?

Share it with your friends, family, or your peers!

In this episode of the Active Ingredients podcast, host Thomas Dove speaks with Alexandre Joyeux, Chief Operating Officer (COO) and President of FatiAbGen International GmbH.

Alexandre Joyeux has led global patient access and market access functions at Novartis and Merck KGaA, shaped a $9 billion gene therapy acquisition, and built biotech organisations with Korean and Asian partners.

In this conversation, he shares how he first learned to lead without formal authority, what it took to step into an interim franchise head role during a blockbuster drug launch, and why he treats patience as a strategic asset when working across cultures. He also offers practical advice on building high-performance teams, career reinvention, and what will separate the best leaders as artificial intelligence (AI) reshapes the workplace.

Key Takeaways

· Learn how trust, curiosity and purpose combine to form a leadership flywheel, and why inspiring others starts with building bridges, not issuing directives.

· Discover how to lead without formal authority by bringing the right external voices into the room to shift perspectives that no internal voice could move.

· Understand what it takes to step fully into an interim role from day one, and why the mental switch matters more than the job title.

· Explore the structured feedback sessions that accelerate trust between new leaders and their teams, and why acting on the outcomes matters as much as receiving them.

· Gain practical advice on building high-performance teams in life sciences, including why a shared vision and a can-do attitude often matter more than the perfect CV.

· Apply the principle of patience as a strategic asset when working across Asian cultures, where investing in relationships before business is a prerequisite, not a courtesy.

· Identify when the moment to reinvent your career has arrived, and how to use purposeful networking to move from large pharma into biotech building.

· Take away a simple principle for cross-cultural working: focus on what unites people first, and differences become far easier to address.

· Consider what will separate the best leaders as AI reshapes the workplace, and why Joyeux believes human qualities such as empathy, intuition and curiosity will matter more, not less.

Snippets

· "It's in your head. It all starts in your head. Right? So if you're all in, then things will flow from that."

· "I thought, if I don't have authority, who does? And it's the customer in the end."

· "Self-awareness sometimes is difficult to have on your own without the feedback and without having a mirror once in a while."

Timestamps & Topics

The following timestamps are approximations:

· [00:27:52] – Intro: Alexandre Joyeux’s career in global biotech and market access

· [00:28:36] – Key Ingredients: Trust, curiosity and purpose as leadership foundations

· [00:31:19] – Early Career: From rural Quebec to biotech via a borrowed conference fee

· [00:37:50] – First Leadership Moment: Influencing without authority at Merck KGaA

· [00:44:39] – Enterprise Leadership: Stepping into the Novartis neuroscience franchise head role

· [01:04:48] – Career Reinvention: Moving from big pharma to building biotech

· [01:11:44] – Cross-Cultural Leadership: Building trust with Korean and Asian partners

· [01:18:23] – Future Trends: AI, pricing pressure and the next generation of life sciences leaders

Resources

· Follow Alexandre Joyeux on LinkedIn: https://www.linkedin.com/in/ajoyeux/

· Follow Thomas Dove on LinkedIn: https://www.linkedin.com/in/lifesciencesexecutivesearch/

Don't Miss an Episode

Sign up to the Active Ingredients podcast at ⁠⁠⁠www.activeingredients.fraserdove.com⁠⁠⁠.

Remember to tune into our next episode for more inspiring insights. You can also subscribe to the Active Ingredients podcast on ⁠⁠⁠Apple Podcasts⁠⁠⁠, ⁠⁠⁠Amazon⁠⁠⁠, ⁠⁠⁠Spotify⁠⁠⁠, ⁠⁠⁠YouTube⁠⁠⁠ and other leading podcast platforms.

Loved this episode?

Share it with your friends, family, or your peers!

In this episode of the Active Ingredients podcast, host Thomas Dove speaks with Aditi Singh Ulvskjold, Vice President, Global Marketing & Urology at Ambu A/S.

Aditi Singh Ulvskjold is a commercial and transformation leader across pharmaceutical and medical device organisations. From dental surgeon to global marketing executive, she has navigated growth, entrepreneurship and reinvention.

She discusses learning, resilience and humility as active ingredients of modern leadership. She shares lessons from founding and closing her own venture, moving from clinical to commercial roles, and adapting to change in life sciences.

Key Takeaways

• Learn why continuous learning helps leaders stay relevant as they move between therapeutic areas and challenges.
• Understand how resilience means dancing as tectonic plates move, maintaining clarity whilst leading through disruption.
• Discover why humility empowers leadership by creating psychological safety for pharmaceutical teams to perform.
• Explore how early mentorship shapes career trajectories, building empathy and purpose for executive roles.
• Apply lessons from entrepreneurship to corporate leadership, including end-to-end thinking and trusted networks.
• Identify how the three Ps framework creates scalable systems that align purpose, people and performance.
• Examine how artificial intelligence and consumer-centricity are reshaping the life sciences, and what leaders must do.

Snippets

• “The currency that human beings trade in is trust. If you fail in that currency, you can forget about the rest of the things." 
• “It's not about the process… It's actually about how we clarified the purpose. And then you get the people, and the multiplication of it will give you the performance."
• "You're the guy who's mopping the floor, but you're on the team that's building that rocket ship to the moon. Just remember that."

Timestamps

• [00:19:40] – Intro: Leadership journey
• [00:21:06] – Key Ingredients: Learning, resilience, humility
• [00:30:09] – Educational Foundation: Early exposure
• [00:36:18] – Career Pivot: Surgery to pharma
• [00:48:31] – Strategic Clarity: Driving business forward
• [00:53:04] – Entrepreneurial Journey: Founding and closing
• [01:02:22] – Three Ps: Purpose, people, performance
• [01:12:04] – Future Leadership: Evolving attributes
• [01:13:59] – Future Life Sciences: AI and consumers

Resources

• Follow Aditi Singh Ulvskjold on LinkedIn: https://www.linkedin.com/in/aditiulvskjold/
• Follow Thomas Dove on LinkedIn: https://www.linkedin.com/in/lifesciencesexecutivesearch/

Don't Miss an Episode

Sign up to the Active Ingredients podcast at ⁠⁠www.activeingredients.fraserdove.com⁠⁠.

Remember to tune into our next episode for more inspiring insights. You can also subscribe to the Active Ingredients podcast on ⁠⁠Apple Podcasts⁠⁠, ⁠⁠Amazon⁠⁠, ⁠⁠Spotify⁠⁠, ⁠⁠YouTube⁠⁠ and other leading podcast platforms.

Loved this episode?

Share it with your friends, family, or your peers!

In this episode of the Active Ingredients podcast, host Thomas Dove interviews Karsten Pietron-Kattmann, Strategic Advisor at k2pharmaCon. 

Karsten Pietron-Kattmann has spent his career leading operational transformation at major pharmaceutical companies including Novartis, GSK, Bayer, and BioNTech, where he played a key role during the Covid vaccine response. 

In this conversation, he shares his framework for aligning strategy, culture, and organisation during transformation. He explains how pharmaceutical leaders can drive change by focusing on what teams can control, tailoring communication to different audiences, and building trust that survives uncertainty. From leading through the Covid vaccine response to managing site divestments during lockdown, Karsten reveals what transformation looks like when strategy meets operational reality. 

Key Takeaways 

• Understand the magic triangle framework that connects strategy, culture, and organisation in pharmaceutical transformation, and why changes fail when leaders underestimate how disruption in one area affects the others. 

• Learn why authenticity forms the foundation of effective leadership in pharmaceutical and biotech organisations, and how trying to be someone else erodes team trust and credibility. 

• Discover how trust operates across three levels in life sciences companies: trusting your employees, trusting your own capabilities, and trusting your organisation to navigate complexity. 

• Understand how early career experiences shape leadership approaches. Karsten Pietron-Kattmann’s path from lab technician to executive taught him empathy for frontline teams and the value of hands-on operational understanding. 

• Explore how collaboration solves problems that individual teams cannot address alone, and why successful leaders look beyond their immediate resources to find solutions across organisations. 

• Gain practical insight into leading global teams across different cultures and accepting that multiple pathways can reach the same goal, even when they differ from your preferred approach. 

• Apply lessons about balancing technology adoption with human-centered leadership as artificial intelligence (AI) and data analytics reshape how life sciences organisations operate and make decisions. 

Snippets 

• “Self-confidence without reflection is not such a sharp knife."  

• "The worst you can do to teams is to take away the purpose of their work and the purpose of their day-to-day efforts. You will have a break of loyalty and integrity in your team." 

• "If you spent most of the time making slides for the review, you will not focus on delivering on the clean room wall, on the HVAC system, on the process machinery." 

  
  

Timestamps & Topics 

The following timestamps are approximations: 

• [21:23] – Intro: Karsten Pietron-Kattmann's leadership journey in biopharma 

• [23:37] – Key Ingredients: Authenticity, trust, curiosity in pharma leadership 

• [26:29] – Career Path: From lab technician to pharmaceutical executive roles 

• [29:31] – Mentorship: Early influences shaping collaboration and problem solving 

• [77:27] – Cultural Leadership: Managing global teams across different methodologies 

• [79:31] – Industry Outlook: Modular manufacturing and AI in life sciences 

• [82:07] – Future Leaders: Embracing diversity and technology in biopharma teams 

  
  

Resources 

• Follow Karsten Pietron-Kattmann on LinkedIn: https://www.linkedin.com/in/karsten-pietron-kattmann-7300ba24/ 

• Follow Thomas Dove on LinkedIn: https://www.linkedin.com/in/lifesciencesexecutivesearch/ 

  
  

  Don't Miss an Episode

  Sign up to the Active Ingredients podcast at ⁠www.activeingredients.fraserdove.com⁠.

  Remember to tune into our next episode for more inspiring insights. You can also subscribe to the Active Ingredients podcast on ⁠Apple Podcasts⁠, ⁠Amazon⁠, ⁠Spotify⁠, ⁠YouTube⁠ and other leading podcast platforms.

  
  

  Loved this episode?

  Share it with your friends, family, or your peers!

In this episode of the Active Ingredients podcast, host Thomas Dove interviews Thomas Jaecklin, Chief Medical Officer and Strategic Pharma Consultant at TJ Pharma Consulting.

Thomas shares his journey from paediatric intensive care physician to C-suite executive, revealing how clinical precision and human-focused leadership create sustainable success in biotech and pharma. The conversation explores trust building, team dynamics, leadership transitions during company maturation phases, and how globalisation is reshaping pharmaceutical leadership.

Key Takeaways

• Learn how generating trust serves as the foundation for effective leadership, creating environments where teams communicate early warnings and innovate freely.
• Discover why vision requires constant communication, as leaders must continuously refocus teams, investors, and partners toward shared goals through repetitive messaging.
• Understand how self-awareness drives leadership development, particularly how doubting yourself can become a strength when it helps identify your own blind spots.
• Explore complexity differences between hospital and pharma leadership, where drug development requires integrating diverse mindsets from commercial, regulatory, safety, and scientific teams.
• Take away frameworks for recognizing leadership expiry dates during transitions, especially when projects move from research to clinical development or development to commercialization.
• Gain insights into building teams using the bicycle wheel analogy, where elements like psychological safety and integrity must be strengthened iteratively rather than focusing on single aspects.
• Apply hiring strategies that prioritize belief over checkbox qualifications, understanding how playing into strengths creates more energised teams than forcing fit against rigid job descriptions.

Snippets

• "Building high performing teams is like building a bicycle wheel… You can't go and connect the hub to the rim and tension that first spoke to the desired tension…, ignoring all the other spokes…"
• “I'd rather play into someone's strengths and try and fill the gaps that this person leaves open…, because that person will be much more motivated, will be much more energised, fulfilled…”
• “It's not the computers or the machines that we buy that make the great work. It's the people that operate those computers and machines…. So why are we treating people so badly?”

Timestamps & Topics

The following timestamps are approximations:

• 00:20:44 - Three Key Ingredients: Trust, vision, and constant communication as leadership foundations
• 00:28:24 -- Transition to Industry: Moving from academic medicine to pharma's collaborative research environment
• 00:32:04 - Becoming a Leader: Recognizing impact through team feedback and psychological safety
• 00:36:19 - Hospital vs. Pharma: Understanding complexity and diverse team mindsets
• 00:44:19 - Leadership Expiry Dates: Navigating transitions from research to development to commercialisation
• 00:54:12 - Building High-Performing Teams: The bicycle wheel framework for iterative trust building
• 01:04:23 - China's Innovation Challenge: How rapid development is reshaping global Pharma

Resources

• Follow Thomas Jaecklin on LinkedIn: https://www.linkedin.com/in/thomas-jaecklin/
• Follow Thomas Dove on LinkedIn: https://www.linkedin.com/in/lifesciencesexecutivesearch/

Don't Miss an Episode

Sign up to the Active Ingredients podcast at www.activeingredients.fraserdove.com.

Remember to tune into our next episode for more inspiring insights. You can also subscribe to the Active Ingredients podcast on Apple Podcasts, Amazon, Spotify,  YouTube and other leading podcast platforms.

Loved this episode?

Share it with your friends, family, or your peers!

In this episode of the Active Ingredients podcast, host Thomas Dove interviews Nageatte Ibrahim, CEO and Founder of Arc Nouvel Clinical Development Consulting LLC.

Ibrahim’s journey spans board-certified medical oncologyist, leadership of oncology trials at Merck, Chief Medical Officer at Arc Nouvel Clinical Development Consulting LLC, and now clinical development consultant for early- and mid-sized biotechs. This episode explores her evolution from hands-on patient care to executive leadership, focusing on the critical balance between clinical excellence and commercial viability. Her insights on building inclusive teams, leading through uncertainty, and maintaining patient focus while scaling biotech organisations offer practical guidance for life sciences executives navigating the modern-day pharmaceutical landscape.

Key Takeaways

• Learn how caring for people forms the foundation of leadership, recognising that, as a leader, you’re entrusted with the careers and futures of others in pharmaceutical and biotech organisations.

• Discover the power of clear focus and realistic goals to align teams behind a shared mission, preventing the chaos that emerges when people move in different directions without understanding their roles.

• Understand the critical distinction between leading and bringing people along, as Ibrahim explains how great leaders avoid leaving team members behind while pursuing business objectives.

• Explore how early mentorship shapes career trajectories through Ibrahim’s experience with hands-on tumor sample research as an undergraduate, demonstrating the lasting impact of invested leadership on emerging talent.

• Take away strategies for growing the next generation of leadership by serving as a model for inclusive, mission-focused team building that develops future pharmal executives.

• Gain insights into leading virtual teams in life sciences, including the essential practice of one-on-one conversations to read what body language and facial expressions cannot reveal on screen.

• Apply frameworks for transitioning between large pharma and biotech environments, understanding when each setting serves different purposes in executive career development and organisational impact.

Snippets

• “If you don't feel nervous about a new opportunity, then you're not really taking on something that's upward growth for you.”

• “You can't plan everything…You have to leave room for the unexpected, which sometimes can turn out to surprise you in great ways.”

• “A lot of focus sometimes is on recruiting the talent. I think the harder part is retaining the talent. And that's where I see not enough investment is made."

Timestamps & Topics

• 00:14:27 - Three Active Ingredients: People, focus, and bringing everyone along on the leadership journey

• 00:17:57 - Early Formation: From first-grade aspiration to molecular biology research with patient tumour samples

• 00:22:00 - University Mentorship: The formative impact of Dr. Eric Rubin’s laboratory on career trajectory

• 00:38:15 - Clinical to Commercial: Transitioning from oncology practice to pharmaceutical leadership at Merck

• 00:45:30 - Leading with Purpose in Biotech: From Oncology Ward to Clinical Consulting with Dr. Nageatte Ibrahim

Resources

• Follow Dr. Nageatte Ibrahim on LinkedIn: https://www.linkedin.com/in/nageatte-ibrahim-m-d-56882b8/

• Follow Thomas Dove on LinkedIn: https://www.linkedin.com/in/lifesciencesexecutivesearch/

Don’t Miss an Episode

Join the Active Ingredients podcast community at https://activeingredients.fraserdove.com to receive new episodes delivered the day they drop, invitation to Active Ingredients Live events and more.

Remember to tune into our next episode for more inspiring insights. You can also subscribe to the Active Ingredients podcast on Apple Podcasts, Spotify, and other leading podcast platforms.

Loved this episode?

Share it with your friends, family, or your peers!